January 22, 2018 – Jubilant Pharma announces the appointment of Chris Preti to the position of President for its allergy company, HollisterStier Allergy.
Mr. Preti has over 25 years of progressive pharmaceutical experience. He began his career at GlaxoSmithKline in research and development, developing products for regulatory submission across multiple therapeutic areas. He then joined a new product marketing team at Merck.
Mr. Preti returned to GSK, joining a management development program and expanding his expertise across various commercial disciplines (marketing, sales & operations). He worked on critical products in the therapeutic fields of CNS and respiratory diseases. Mr. Preti took on senior leadership roles across operations where he influenced marketing and sales effectiveness of over 4500 employees. In his most recent position, Mr. Preti was Vice President, COPD Marketing where he was fully responsible for the entire respiratory COPD portfolio of products, along with critical new launches.
Mr. Preti holds a Masters of Science in Chemistry from Furman University, South Carolina and has also completed a Masters of International Business Studies at Darla Moore School of Business, South Carolina University along with Wharton’s School of Business Transformational Leadership program for executives in Pennsylvania.
Mr. Preti and his family will be relocating to Spokane, WA from North Carolina.
